Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Remdesivir

NIH Funds Phase 1 Safety Study Comparing Use of Remdesivir in Pregnant Women Hospitalized with COVID-19 to Women Not Pregnant

The National Institutes of Health (NIH) along with their National Institutes of Child Health and Human Development (NICHD) and the […]

NIH Funds Phase 1 Safety Study Comparing Use of Remdesivir in Pregnant Women Hospitalized with COVID-19 to Women Not Pregnant
2 weeks ago
Share

Inhalable Remdesivir at Contacts or Early Onset Could Generate Large Growth for Remdesivir—Still in Early Stages Investigation

Gilead’s inhaled version of remdesivir (Veklury) could add considerable value to the COVID-19 market. Potentially, the drug could be used […]

Inhalable Remdesivir at Contacts or Early Onset Could Generate Large Growth for Remdesivir—Still inEarly Stages Investigation
3 weeks ago
Share

WHO Declares Drugs Like Remdesivir Don’t Reduce Mortality or Even Duration of Hospitalization: Other Data Refutes This Position However

The World Health Organization (WHO) has shared interim results from the international, open-label trial published recently in the New England […]

WHO Declares Drugs Like Remdesivir Don’t Reduce Mortality or Even Duration of Hospitalization Other Data Refutes This Position However
1 month ago
Share

COVID-19 Cases “Drastically’ Dropping in India Leading to Glut of Antivirals Remdesivir & Favipiravir

With the COVID-19 pandemic conditions improving in India according to some local reports, the demand for antiviral drugs Remdesivir and […]

COVID-19 Cases “Drastically’ Dropping in India Leading to Glut of Antivirals Remdesivir & Favipiravir
2 months ago
Share

University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients

Much attention was placed on the antiviral drug remdesivir during the early stages of the COVID-19 pandemic. In fact, considerable public […]

University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients
2 months ago
Share

NIAID’s ACTT-2: Hospitalized COVID-19 Patients Fare Better on Lilly’s Baricitinib & Remdesivir vs. Remdesivir Alone: Triggered FDA EUA in Nov. 2020

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institute of Health (NIH), recently produced results […]

NIAID’s ACTT-2 Hospitalized COVID-19 Patients Fare Better on Lilly’s Baricitinib & Remdesivir vs. Remdesivir Alone Triggered FDA EUA in Nov. 2020
2 months ago
Share

Eli Lilly and Company and Incyte Announce Results of Phase 3 Study Using Baricitinib in Combination with Remdesivir

This week, Eli Lilly and Company and Incyte announced the publication of the New England Journal of Medicine’s peer-reviewed results […]

Eli Lilly and Company and Incyte Announce Results of Phase 3 Study Using Baricitinib in Combination with Remdesivir
3 months ago
Share

World Health Organization Panel: Do Not Recommend Remdesivir for COVID-19 Patients Under Any Circumstances

The World Health Organization (WHO) advises against using Remdesivir under any circumstances. Apparently, a prominent group of intensive care doctors […]

World Health Organization Panel Do Not Recommend Remdesivir for COVID-19 Patients Under Any Circumstances
4 months ago
Share

Are Politics & Power Behind the Rise of Remdesivir?

In the early stages of the COVID-19 pandemic, those involved in monitoring new drugs that may help inhibit the SARS-CoV-2 […]

Are Politics & Power Behind the Rise of Remdesivir
4 months ago
Share

Will Remdesivir Become & Remain a Blockbuster? Listen to ‘The Fool’

Keith Speights writes for investment advisory website Motley Fool and brings the eclectic and varied background TrialSite appreciates. Mr. Speight highlighted […]

Will Remdesivir Become & Remain a Blockbuster Listen to ‘The Fool’
4 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.